A Simple Stereoselective Synthesis of the Cholesterol Absorption Inhibitor (-)-SCH 48461

Synthesis ◽  
1996 ◽  
Vol 1996 (07) ◽  
pp. 819-820 ◽  
Author(s):  
Manfred Braun ◽  
Dietmar Galle
2016 ◽  
Author(s):  
Marek Chmielewski

The copper(I)-mediated reaction of nitrones with terminal acetylenes, known as the Kinugasa reaction, represents an attractive method of direct formation of the β-lactam ring. The reaction can be performed in many ways. Diastereoselective versions, including cyclic chiral nitrones or chiral acetylenes and open-chain nitrones, are the most attractive. An alternative method yielding β-lactams with high stereoselectivity, in which nitrones are used, is their 1,3-dipolar cycloaddition to unsaturated lactones. After N- O bond cleavage, cycloadducts can be easily transformed into β-lactams via an intramolecular acylation of the nitrogen atom. Both methodologies are demonstrated in the synthesis of carbapenems (Thienamycin and 4AA azetidinone), monobactams (Carumonam) and Ezetimibe, a powerful cholesterol absorption inhibitor.


2016 ◽  
Author(s):  
Marek Chmielewski

The copper(I)-mediated reaction of nitrones with terminal acetylenes, known as the Kinugasa reaction, represents an attractive method of direct formation of the β-lactam ring. The reaction can be performed in many ways. Diastereoselective versions, including cyclic chiral nitrones or chiral acetylenes and open-chain nitrones, are the most attractive. An alternative method yielding β-lactams with high stereoselectivity, in which nitrones are used, is their 1,3-dipolar cycloaddition to unsaturated lactones. After N- O bond cleavage, cycloadducts can be easily transformed into β-lactams via an intramolecular acylation of the nitrogen atom. Both methodologies are demonstrated in the synthesis of carbapenems (Thienamycin and 4AA azetidinone), monobactams (Carumonam) and Ezetimibe, a powerful cholesterol absorption inhibitor.


2000 ◽  
Vol 129 (8) ◽  
pp. 1748-1754 ◽  
Author(s):  
Margaret Van Heek ◽  
Constance Farley ◽  
Douglas S Compton ◽  
Lizbeth Hoos ◽  
Kevin B Alton ◽  
...  

Antioxidants ◽  
2020 ◽  
Vol 9 (4) ◽  
pp. 349 ◽  
Author(s):  
Denise Peserico ◽  
Chiara Stranieri ◽  
Ulisse Garbin ◽  
Chiara Mozzini C ◽  
Elisa Danese ◽  
...  

Background: While reperfusion is crucial for survival after an episode of ischemia, it also causes oxidative stress. Nuclear factor-E2-related factor 2 (Nrf2) and unfolded protein response (UPR) are protective against oxidative stress and endoplasmic reticulum (ER) stress. Ezetimibe, a cholesterol absorption inhibitor, has been shown to activate the AMP-activated protein kinase (AMPK)/Nrf2 pathway. In this study we evaluated whether Ezetimibe affects oxidative stress and Nrf2 and UPR gene expression in cellular models of ischemia-reperfusion (IR). Methods: Cultured cells were subjected to simulated IR with or without Ezetimibe. Results: IR significantly increased reactive oxygen species (ROS) production and the percentage of apoptotic cells without the up-regulation of Nrf2, of the related antioxidant response element (ARE) gene expression or of the pro-survival UPR activating transcription factor 6 (ATF6) gene, whereas it significantly increased the pro-apoptotic CCAAT-enhancer-binding protein homologous protein (CHOP). Ezetimibe significantly decreased the cellular ROS formation and apoptosis induced by IR. These effects were paralleled by the up-regulation of Nrf2/ARE and ATF6 gene expression and by a down-regulation of CHOP. We also found that Nrf2 activation was dependent on AMPK, since Compound C, a pan inhibitor of p-AMPK, blunted the activation of Nrf2. Conclusions: Ezetimibe counteracts IR-induced oxidative stress and induces Nrf2 and UPR pathway activation.


Sign in / Sign up

Export Citation Format

Share Document